Jennifer Jarrett Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer Jarrett.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer Jarrett. Jennifer Jarrett is Chief Financial Officer in MEDIVATION, INC. ($MDVN) and Director in ARENA PHARMACEUTICALS INC ($ARNA) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Audentes Therapeutics, Inc. ($BOLD) and Chief Operating Officer in Arcus Biosciences, Inc. ($RCUS) and Director in Arcus Biosciences, Inc. ($RCUS) and See Remarks in Arcus Biosciences, Inc. ($RCUS).
Latest Insider Trading Transactions of Jennifer Jarrett
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RCUS, ARNA, BOLD, MDVN, SNDX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 65.19 | 7,202 | 469,498 | 7,202 | |
| Jun 15 2021 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,067 | 0 | 11,217 | 8.2 K to 11.2 K (+37.63 %) |
| Mar 18 2021 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Sell | S | 35.03 | 8,661 | 303,394 | 116,973 | 125.6 K to 117 K (-6.89 %) |
| Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Jarrett Jennifer | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
| Jan 20 2021 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Grant | A | 0.00 | 400,000 | 0 | 500,634 | 100.6 K to 500.6 K (+397.48 %) |
| Oct 05 2020 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Chief Operating Off ... | Option Exercise | A | 17.17 | 900,000 | 15,453,000 | 900,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 61.31 | 5,000 | 306,550 | 5,000 | |
| Jun 16 2020 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 2,446 | 0 | 8,150 | 5.7 K to 8.2 K (+42.88 %) |
| Jun 08 2020 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Director | Option Exercise | A | 30.05 | 14,000 | 420,700 | 14,000 | |
| Jun 08 2020 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,000 | 0 | 103,634 | 100.6 K to 103.6 K (+2.98 %) |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | D | 24.74 | 16,200 | 400,788 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | D | 38.65 | 10,000 | 386,500 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | D | 26.15 | 9,000 | 235,350 | 0 | |
| Jan 15 2020 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | D | 14.70 | 18,000 | 264,600 | 0 | |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 56.50 | 5,000 | 282,500 | 5,000 | |
| Jun 17 2019 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 2,654 | 0 | 5,704 | 3.1 K to 5.7 K (+87.02 %) |
| Jun 12 2019 | SNDX | Syndax Pharmaceuti ... | Jarrett Jennifer | Option Exercise | A | 7.88 | 24,000 | 189,120 | 24,000 | ||
| Jun 10 2019 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Director | Option Exercise | A | 7.99 | 35,000 | 279,650 | 35,000 | |
| Feb 08 2019 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
| Jan 15 2019 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Director | Option Exercise | A | 9.07 | 35,000 | 317,450 | 35,000 | |
| Jan 15 2019 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | Director | Option Exercise | A | 9.07 | 35,000 | 317,450 | 35,000 | |
| Sep 27 2018 | SNDX | Syndax Pharmaceuti ... | Jarrett Jennifer | Option Exercise | A | 7.11 | 35,000 | 248,850 | 35,000 | ||
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 49.17 | 5,000 | 245,850 | 5,000 | |
| Jun 15 2018 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Grant | A | 0.00 | 3,050 | 0 | 3,050 | 0 to 3.1 K |
| Jun 12 2018 | RCUS | Arcus Biosciences, ... | Jarrett Jennifer | See Remarks | Option Exercise | A | 16.95 | 161,114 | 2,730,882 | 161,114 | |
| Jun 08 2018 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
| Oct 10 2017 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 26.01 | 9,000 | 234,090 | 9,000 | |
| Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 1.36 | 150,000 | 204,000 | 150,000 | |
| Jun 14 2017 | ARNA | ARENA PHARMACEUTIC ... | Jarrett Jennifer | Director | Option Exercise | A | 1.36 | 75,000 | 102,000 | 75,000 | |
| Jun 13 2017 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 14.70 | 18,000 | 264,600 | 18,000 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | Jarrett Jennifer | Chief Financial Off ... | Option Exercise | D | 0.00 | 37,463 | 0 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | Jarrett Jennifer | Chief Financial Off ... | Option Exercise | D | 46.45 | 119,885 | 5,568,658 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | Jarrett Jennifer | Chief Financial Off ... | Sell | D | 0.00 | 29,971 | 0 | 0 | 30 K to 0 (-100.00 %) |
| Apr 08 2016 | MDVN | MEDIVATION, INC. | Jarrett Jennifer | Chief Financial Off ... | Option Exercise | A | 46.45 | 119,885 | 5,568,658 | 119,885 | |
| Apr 08 2016 | MDVN | MEDIVATION, INC. | Jarrett Jennifer | Chief Financial Off ... | Grant | A | 0.00 | 29,971 | 0 | 29,971 | 0 to 30 K |
Page: 1